Three step high-dose chemotherapy in poor prognosis non-Hodgkin lymphoma.

被引：0
|
作者：
Ballestrero, A
Clavio, M
Ferrando, F
Secondo, V
Basta, P
Gonella, R
Garuti, A
Miglino, M
Pierri, I
Canepa, L
Beltrami, G
Vallebella, E
Ghio, R
Gobbi, M
Patrone, F
机构：
[1] Univ Genova, Sez Oncol & Ematol DIML, Genoa, Italy
[2] OC Galliera, Div Med, Genova, Italy
来源：
BONE MARROW TRANSPLANTATION | 1998年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
613
引用
收藏
页码：S177 / S177
页数：1
相关论文
共 50 条
  • [21] Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy
    Janicek, M
    Kaplan, W
    Neuberg, D
    Canellos, GP
    Shulman, LN
    Shipp, MA
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) : 1631 - 1637
  • [22] Dose escalation of high-dose cyclophosphamide and etoposide with high-dose doxorubicin (CDE) and filgrastim for poor-risk non-Hodgkin's lymphoma
    Juliusson, G
    Liliemark, J
    ANNALS OF ONCOLOGY, 1996, 7 (10) : 1037 - 1041
  • [23] High dose chemotherapy and autologous transplantation for non-Hodgkin’s lymphoma
    Julie M. Vose
    International Journal of Hematology, 2002, 76 : 115 - 115
  • [24] High dose chemotherapy and autologous transplantation for non-Hodgkin's lymphoma
    Vose, JM
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (Suppl 2) : 115 - 115
  • [25] Is high-dose radioimmunotherapy needed in non-Hodgkin's lymphoma? Against
    von Schilling, C
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (09) : 1254 - 1256
  • [26] Aggressive non-Hodgkin's lymphoma - Economics of high-dose therapy
    Beard, SM
    Wall, L
    Gaffney, L
    Sampson, F
    PHARMACOECONOMICS, 2004, 22 (04) : 207 - 224
  • [27] Rituximab in vivo purging combined with auto peripheral blood stem cell transplantation (APBST) and high-dose chemotherapy in non-Hodgkin's lymphoma.
    Shi, YK
    BLOOD, 2003, 102 (11) : 481B - 481B
  • [28] High-dose sequential (RDS) chemotherapy with high-dose ARA-C and Rituximab prolongs the survival of patients with resistant/relapsed B-cell non-Hodgkin's lymphoma.
    Cortelazzo, S
    Rambaldi, A
    Rossi, A
    Oldani, E
    Bellavita, P
    Motta, T
    Barbui, T
    BLOOD, 2002, 100 (11) : 646A - 646A
  • [29] Fatal leukoencephalopathy in a patient with non-Hodgkin's lymphoma treated with CHOP chemotherapy and high-dose steroids
    Cain, MS
    Burton, GV
    Holcombe, RF
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1998, 315 (03): : 202 - 207
  • [30] LymphDx: A custom microarray for molecular diagnosis and prognosis in non-Hodgkin lymphoma.
    Dave, SS
    Wright, G
    Tan, B
    Rosenwald, A
    Chan, WC
    Greiner, TC
    Weisenburger, DD
    Lynch, JC
    Vose, JM
    Armitage, JO
    Fisher, RI
    Braziel, RM
    Rimsza, LM
    Grogan, TM
    Miller, TP
    LeBlanc, M
    Smeland, EB
    Kvaloy, S
    Holte, H
    Delabie, J
    Muller-Hermelink, HK
    Ott, G
    Gascoyne, RD
    Connors, JM
    Campo, E
    Montserrat, E
    Wilson, WH
    Jaffe, ES
    Lister, TA
    Davies, AJ
    Norton, AJ
    Simon, R
    Yang, L
    Powell, J
    Palma, J
    Warrington, J
    Zhao, H
    Chiorazzi, M
    Staudt, LM
    BLOOD, 2004, 104 (11) : 201A - 201A
12345